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Objectives   The etiology of male breast cancer (MBC) is largely unknown but a causal role of exposure to 
organic solvents has been suggested. Previous studies on occupational risk factors of breast cancer were often 
restricted to women who are frequently exposed to lower levels and at a lower frequency than men. We inves-
tigated the association between MBC and occupational exposure to petroleum and oxygenated and chlorinated 
solvents in a multicenter case–control study of rare cancers in Europe.
Methods   The study included 104 MBC cases and 1901 controls. Detailed lifetime work history was obtained 
during interviews, together with sociodemographic characteristics, medical history and lifestyle factors. Occu-
pational exposures to solvents were estimated from a job-exposure matrix. Odds ratios (OR) and their 95% 
confidence intervals (CI) were calculated using unconditional logistic regression models. 
Results   Lifetime cumulative exposure to trichloroethylene >23.9 ppm years was associated with an increased 
MBC risk, compared to non-exposure [OR (95% CI): 2.1 (1.2–4.0); P trend <0.01). This increase in risk persisted 
when only exposures that occurred ≥10 years before diagnosis were considered. In addition, a possible role for 
benzene and ethylene glycol in MBC risk was suggested, but no exposure–response trend was observed. 
Conclusions   These findings add to the evidence of an increased risk of breast cancer among men professionally 
exposed to trichloroethylene and possibly to benzene or ethylene glycol. Further studies should be conducted in 
populations with high level of exposure to confirm our results. 
Key terms   alcoholic solvent; benzene; chlorinated solvent; ethylene glycol; JEM; job-exposure matrix; petro-
leum solvent; trichloroethylene. 
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Organic solvents and male breast cancer
Breast cancer is the most frequent cancer among women, 
with over 1.6 million new cases in 2012 across the world 
(1), but it is a rare disease among men, accounting for 
<1% of all breast cancers (2). Risk factors related to 
hormones and reproduction are well-established causes 
of female breast cancer, but the etiology of male breast 
cancer (MBC) is largely unknown (3). However, the 
clinical features of MBC are often similar to those of the 
late-onset type of female breast tumors (4), suggesting 
that these two conditions may share some risk factors. 
The risk factors for MBC that have been investigated 
so far include genetics (family history of breast cancer, 
mutations in BRCA2 or CHEK2), conditions associated 
with an abnormal estrogen-to-androgen ratio (Klinefel-
ter’s syndrome, obesity, orchitis, infertility, exogenous 
estrogen or testosterone use), and lifestyle (lack of 
physical activity, alcohol consumption) (3, 5, 6). 
Environmental and occupational factors are also 
suspected to play a role in the etiology of breast cancer 
in both sexes (7, 8). Solvents are ubiquitous chemicals 
in occupational settings. They have retained particular 
attention because they are highly lipophilic compounds 
that can accumulate in the adipose tissue of the breast 
and initiate or promote carcinogenesis through geno-
toxic mechanisms (9). Because of the high prolifera-
tive activity of epithelial cells of the mammary gland 
and susceptibility to chemical carcinogens, mammary 
terminal duct lobular units are likely target tissues for 
tumorigenesis (10). Animal studies have provided strong 
evidence for an association between organic solvents 
and breast cancer (11), and the International Agency 
for Research on Cancer (IARC) has recognized solvents 
such as benzene and trichloroethylene (TCE) as known 
human carcinogens. However, there are limited data on 
solvents as human breast carcinogens (12, 13). 
The major families of solvents used in the work places 
include petroleum, chlorinated and oxygenated solvents. 
Petroleum solvents consist of fuel and organic solvents 
produced by oil refining. The main petroleum solvent, 
benzene, was initially used as industrial solvent, eg, to 
degrease metals, besides being a constituent of gasoline. 
The toxicity of benzene has largely been proven in leuke-
mia risk (14). Its use has now been restricted as an inter-
mediate for the synthesis of other chemicals. Chlorinated 
solvents including TCE, perchloroethylene or methylene 
chloride, are usually used as solvents in paints, paint 
removers or resines, chemical intermediates for pesticide 
synthesis, in dry-cleaning and in the steel industry. Most 
of them have been used as solvents in place of benzene. 
Oxygenated solvents include alcohols, ketones, esters, 
ethylene glycol, or tetrahydrofurans and are widely used 
in the paint, ink, pharmaceutical, fragrance, adhesive, 
cosmetic, detergent, or food industries. Ethylene glycol, 
in particular, is used as a sterilizing agent for medical 
equipment and supplies.
A limited number of epidemiological studies have 
investigated the role of organic solvents in female 
breast cancer, and the increases were either small or 
inconsistent (15–22). Only two studies have considered 
MBC in relation to occupational exposure to solvents 
(23, 24). Because occupational exposures to many 
chemicals, including solvents, are usually present in jobs 
mostly held by men (eg, mechanics or painters), studies 
among men with higher prevalence of exposure than 
women and less competing risk factors (eg, hormonal 
and reproductive factors) may facilitate the detection of 
an association between exposure to solvents and breast 
cancer, despite the rarity of the disease in men. 
In a previous paper based on data from a European 
case–control study on rare cancers including 104 cases 
of MBC (25), we reported that motor vehicle mechanics 
and painters with probable exposure to organic solvents 
had a two- to threefold increased risk of MBC. To further 
evaluate the hypothesis that organic solvents increases 
the incidence of MBC, we specifically assessed lifetime 
occupational exposure to organic solvents by solvent 
subtype using a detailed job exposure matrix (JEM) (26). 
Methods
We conducted a European multi-center retrospective 
case–control study on occupational risk factors of seven 
rare cancer sites (gallbladder and extra-hepatic bile ducts, 
small intestine, bone, eye melanoma, mycosis fungoides, 
and male breast). Cases and controls were recruited from 
selected areas of eight European countries (Denmark, 
France, Germany, Italy, Latvia, Portugal, Spain and 
Sweden) representing a source population of 37 million 
people. The study design and the procedures of data col-
lection have been described in detail earlier (25, 27) and 
are summarized below. The local ethics committees in 
each participating country approved the study.
Recruitment of cases and controls  
Men living in the study areas who were diagnosed with a 
breast cancer between 1995 and 1997, aged 35–70 years 
at diagnosis were eligible for inclusion in the study. This 
age range was based on the assumption that occupational 
exposures are not likely to be the cause of the disease 
in younger patients. 
Case ascertainment was based on regular contacts 
with clinical and pathology departments and/or cancer 
registers in each study area. For each case, an expert 
pathologist reviewed the pathology report and, if pos-
sible, a representative histological slide of the tumor. In 
total, 122 MBC patients were eligible for the study from 
all the countries. Eighteen cases could not be included 
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because the doctor did not give permission to contact the 
patient or the patient refused to participate. Thus, 104 
cases (85%) were interviewed and available for analysis. 
The controls were selected randomly from population 
registers in Denmark, Italy, and Sweden, from electoral 
rolls in France and from municipality registers in Germany 
during the case recruitment period and were frequency-
matched to the cases by gender, year of birth (5-year strata), 
and residence area. In countries where population controls 
were difficult to identify, colon and stomach cancer patients 
were regarded as appropriate alternatives to population 
controls, as no occupational exposure to organic solvents 
is suspected to play an important role in these cancers. 
Hospital-based cancer controls were selected randomly 
among incident colon cancer patients in Latvia and Spain, 
and among colon or stomach cancer patients in Portugal. 
The controls served as a common pool of controls for each 
of the seven groups of rare cancer cases included in the 
European study. The participation rate among male popula-
tion controls was high in France (81%) and Italy (74%) but 
relatively low in Denmark, Germany, and Sweden (<60%). 
In countries using a hospital-based design, the participation 
rate among cancer controls was >95%. The overall partici-
pation rate among controls was 67%. For the present study, 
we selected only male controls sampled in study areas from 
which ≥1 MBC patient was included. Finally, 1901 male 
controls (1395 population controls and 506 cancer controls) 
were available for the analyses.
Data collection
A structured questionnaire was first developed in English, 
and then translated into the language of each participating 
country. Back-translation to English was performed for 
quality control, and no major departure from the original 
version was observed. A trained interviewer administered 
this questionnaire face to face or by telephone and col-
lected information on socio demographic characteristics, 
previous medical conditions, lifestyle factors, anthropo-
metric characteristics, alcohol and tobacco consumption, 
and detailed occupational activities in each job held for 
>6 months. For each occupational period, we recorded 
data on products and production processes, the year the 
job started and ended, job title, and working hours per 
week. The materials handled, chemical exposures, and 
occupations held by nearby workers were also recorded. 
The specific nature of the work was also addressed, such 
as work tasks, machines or products used, and duration 
of their use (hours per week). Specific questionnaires 
were also developed for 27 definite jobs or tasks, such as 
welding or painting. 
Exposure assessment
As previously described, trained coders coded the jobs 
(28). Briefly, occupation was coded according to the 
International Standard Classification of Occupations of 
the International Labor Office (ISCO), 1968 revision, 
while industry was coded according to the Classifica-
tion of Activities in the European Community (NACE), 
1996 revision.
Occupational exposures to organic solvents were 
assessed using JEM developed at the Occupational 
Health Department of the French National Agency 
for Public Health (Santé Publique France) by experts 
in occupational hygiene (29, 30). Jobs were defined 
according to both the ISCO code and the Nomenclature 
d’Activité Française (NAF: Institut National de la Statis-
tique et des Etudes Economiques, revision 1, 2003), 
subsequently converted to the European NACE code 
for the purpose of this study. Exposures to occupational 
hazards were assessed by job and calendar period to 
account for changes in exposures over time. 
In the JEM, exposure to chlorinated solvents [TCE, 
perchloroethylene (tetrachloroethylene), methylene 
chloride (dichloromethane), chloroform (trichloro-
methane) and carbon tetrachloride], petroleum sol-
vents [benzene, special boiling point spirits and other 
aliphatic petroleum-based solvents (SBP), gasoline, 
white spirits, and kerosene/diesel oil/fuel oils (KDF)] 
and to oxygenated solvents (alcohol, ketones/esters, 
diethyl ether, ethylene glycol and tetrahydrofuran) was 
determined for each job using semi-quantitative indica-
tors for exposure probability (ie, proportion of exposed 
workers 0, 0–10, 10–20, … ≥90%), exposure frequency 
(eg, for petroleum solvents 1=<30%, 2=30–70%, 3= 
>70% of working hours) and exposure intensity [semi-
quantitative exposure scores on the basis of literature 
review of occupational measurement data, for example, 
for benzene: 1=0.1–1 ppm, 2>1–5 ppm, 3=>5–15 ppm, 
and 4=>15 ppm].
Each job held by a case or a control included in 
the European study was assigned the exposure indices 
reported in the JEM. In order to improve specificity, 
exposure to a given solvent was assigned only to jobs 
whose probability of exposure according to the JEM was 
>10%, while the jobs below this cut-off were consid-
ered as non-exposed. A job-specific exposure score was 
then calculated as the result of the product of exposure 
probability, frequency and intensity, and duration of the 
job in years. An individual Cumulative Exposure Score 
(CES) was then calculated for each study subject as the 
sum of the job-specific exposure scores over his entire 
work history.
Statistical analysis
The distributions of baseline characteristics of study 
population according to cases and controls status were 
expressed as means and standard deviation (SD) for con-
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tinuous variables or number (percentage) for dichotomous 
variables. The CES was categorized into “not exposed” 
plus two classes of exposed workers, according to the 
median among the exposed controls. Regarding ethylene 
glycol and tetrahydrofuran, subjects were simply defined 
as “never or ever exposed” because of the small number 
of exposed workers. We could not estimate associations 
between MBC and exposure to perchloroethylene, carbon 
tetrachloride, chloroform and diethyl ether because no 
case of breast cancer was exposed to these solvents. 
We conducted unconditional logistic regressions 
to estimate odds ratios (OR) and their 95% confidence 
intervals (95% CI) adjusting for age, country, alcohol 
intake in three categories (0–≥30; >30–≤60; >60 g/day), 
education in three categories (left school at age ≤18; 
professional training; university) and body mass index 
(BMI) in four categories (≤18.5, >18.5–≤25, >25–≤30 
and >30 kg/m²) as these variables are potentially associ-
ated with both breast cancer and solvent exposure. We 
used three different models: model A where each solvent 
was included separately; model B where all solvents 
where included simultaneously to control for potential 
confounding between exposures; model C using a step-
wise multiple logistic regression method that allowed 
dropping and adding solvents at each step to identify 
independent predictors of MBC. F probabilities were 
used as stepping criteria: 0.05 was the entry cut-off and 
0.10 was the removal cut-off (31).
All analyses were performed using Statistical Analy-
sis Systems (SAS) software, version 9.3 (SAS Institute, 
Inc, Cary, NC, USA).
Results
The main characteristics of cases (N=104) and controls 
(N=1901) are presented in table 1. Compared to con-
trols, cases tended to be older and have a lower educa-
tion level. The BMI and the mean number of jobs did not 
differ significantly. An elevated consumption of alcohol 
>60 g/day was associated with a 2.6 increased risk of 
MBC, as reported in a previous paper (5). 
The proportion of men ever exposed to organic sol-
vent of any kind was higher among cases than among 
controls (table 2). As regards the most common expo-
sures, 44% of the cases and 32% of the controls had been 
exposed to TCE, 30% and 20% respectively to white 
spirits, 21% and 17% to KDF, 21% and 9% to benzene. 
Each of the other exposures accounted for ≤10% of cases 
and controls. Each subject was typically exposed to more 
than one substance. For example, 144 subjects had been 
exposed to both benzene and TCE, a number that repre-
Table 1. Comparison of cases and controls by selected character-
istics (European study on male breast cancer) [BMI=body mass 







OR a 95% CI
N % N %
Country      
Denmark 8 7.7 195 10.3  
Sweden 7 6.7 140 7.4  
Latvia 3 2.9 69 3.6  
France 29 27.9 308 16.2  
Germany 10 9.6 542 28.5  
Italy 20 19.2 210 11  
Spain 19 18.3 365 19.2  
Portugal 8 7.7 72 3.8  
Age (years)      
<40 6 5.8 218 11.5  
40–44 6 5.8 193 10.1  
45–49 10 9.6 190 10  
50–54 14 13.4 202 10.6  
55–59 16 15.4 264 13.9  
60–64 20 19.2 329 17.3  
≥65 32 30.8 505 26.6  
Alcohol intake (g/day)     
0–30 43 41.4 1130 59.4 1.0 reference
30–60 31 29.8 503 26.5 1.3 0.8–2.2
>60 30 28.8 268 14.1 2.6 1.5–4.4
Education b      
Left school at ≤18 63 60.6 866 45.6 1.5 0.8–2.8
Professional 
training
25 24.0 515 27.1 1.5 0.8–2.9
University 16 14.4 516 27.1 1.0 reference
BMI (kg/m²)      
<18.5 8 7.7 83 4.4 2.0 0.9–4.7
18.5–25 40 38.5 733 38.6 1.0 reference
25–30 40 38.5 883 46.4 0.8 0.5–1.3
>30 16 15.4 202 10.6 1.5 0.8–2.7
a Adjusted for age and country.
b Four missing values. 
Table 2. Prevalence of occupational exposure to organic solvents 
for cases and controls (European study on male breast cancer) 
[KDF=kerosene/diesel oil/fuels oil; SBP=special-boiling-point spirits]
Solvents Cases (N=104)  
ever exposed
Controls (N=1901)  
ever exposed
 N % N %
Petroleum solvents    
Benzene 22 21.1 178 9.3
SBP 6 5.7 83 4.3
Gasoline 9 8.6 112 5.8
White spirits 31 29.8 376 19.7
KDF 22 21.1 317 16.6
Chlorinated solvents    
Trichloroethylene 46 44.2 613 32.2
Perchloroethylene 0 0.0 16 0.8
Methylene chloride 8 7.6 96 5.0
Chloroform 0 0.0 6 0.3
Carbon tetrachloride 0 0.0 1 0.0
Oxygenated solvents    
Alcohol 10 9.6 171 8.9
Ketones/esters 11 10.5 137 7.2
Diethyl ether 0 0.0 11 0.5
Ethylene glycol 5 4.8 25 1.3
Tetrahydrofuran 2 1.9 8 0.4
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sented 72% of all those exposed to benzene (N=200) and 
21% of all those exposed to TCE (N=659).
Table 3 shows the adjusted OR for MBC associated 
with cumulative exposure scores of organic solvents 
obtained with three different models. 
Among the petroleum solvents, significant two- to 
threefold increased OR were observed in all the models 
for the low benzene exposure levels compared to non-
exposure. The narrower CI were observed in model C, 
which reports a 2.2 increase in risk. However the OR 
were smaller and did not reach statistical significance 
in the high exposure group.  
High exposures to gasoline, white spirits and KDF 
were associated with similarly increased OR of 1.9, 1.8, 
and 1.7, respectively, using model A where each solvent 
was included separately. However no evidence of associa-
tion was found in model B including all the solvents at 
a time. Exposure to SBP was not associated with MBC.
For chlorinated solvents, high exposure to TCE 
was associated with OR≈2 in all models, with a dose–
response trend (P<0.01). The three models gave very 
similar estimates, including the one with stepwise vari-
able selection. 
Low level exposure to methylene chloride was associ-
ated with an OR of 2.4 in model A, but this decreased to 1.9 
and was non-significant after adjustment for other solvents 
Table 3. Odds ratios (OR) for male breast cancer for exposure to organic solvents. [CES=cumulative exposure score; CI=confidence 
interval; KDF=kerosene/diesel oil/fuel oils; SBP=special-boiling-point spirits]
Solvent CES (ppm.
years)




Model A a Model B b Model C c
OR 95% CI OR 95% CI OR 95% CI
Benzene
Not exposed 82 1723 1.0 reference 1.0 reference 1.0 reference
>0–<0.87 13 89 2.6 1.3–5.1 3.1 1.1–8.9 2.2 1.1–4.3
≥0.87 9 89 1.9 0.9–4.1 2.6 0.7–9.4 1.5 0.7–3.4
 Gasoline        
Not exposed 95 1789 1.0 reference 1.0 reference Not selected
>0–<0.16 4 56 1.3 0.4–3.8 1.2 0.4–3.6   
≥ 0.16 5 56 1.9 0.7–5.0 0.7 0.2–3.0   
SBP        
Not exposed 98 1818 1.0 reference 1.0 reference Not selected
>0–<1.10 3 42 1.1 0.3–3.8 0.5 0.1–1.8   
≥1.10 3 41 1.2 0.4–4.2 0.6 0.1–2.6   
White spirits        
Not exposed 73 1525 1.0 reference 1.0 reference Not selected
>0–<0.13 14 188 1.5 0.8–2.8 0.9 0.4–2.0   
≥0.13 17 188 1.8 1.0–3.1 0.8 0.3–2.1   
KDF        
Not exposed 82 1584 1.0 reference 1.0 reference Not selected
>0–<0.08 9 158 1.1 0.6–2.4 0.8 0.4–1.8   
≥0.08 13 159 1.7 0.9–3.3 0.9 0.4–2.1   
Trichloroethylene       
Not exposed 58 1288 1.0 reference 1.0 reference 1.0 reference
>0–<23.90 17 306 1.5 0.8–2.8 1.3 0.7–2.6 1.4 0.7–2.5
≥23.90 29 307 2.2 1.3–3.7 2.1 1.2–4.0 1.9 1.1–3.3
Methylene chloride        
Not exposed 96 1805 1.0 reference 1.0 reference Not selected
>0–<17.71 6 49 2.4 1.0–6.0 1.9 0.7–5.1   
≥17.71 2 47 0.7 0.2–2.9 0.5 0.1–2.6   
Alcohol        
Not exposed 94 1730 1.0 reference 1.0 reference Not selected
>0–<10.25 7 84 1.9 0.8–4.3 1.3 0.5–3.4   
≥10.25 3 87 0.6 0.2–2.1 0.6 0.2–2.7   
Ketones/esters        
Not exposed 93 1764 1.0 reference 1.0 reference Not selected
>0–<20.25 7 70 2.0 0.9–4.6 1.4 0.5–3.7   
≥20.25 4 67 1.0 0.3–2.8 1.1 0.3–4.5   
Ethylene glycol        
Not exposed 99 1876 1.0 reference 1.0 reference Not selected
Exposed 5 25 2.4 1.1–4.9 1.1 0.4–3.1   
Tetrahydrofuran        
Not exposed 102 1893 1.0 reference 1.0 reference Not selected
Exposed 2 8 0.7 0.2–3.0 0.4 0.1–2.6   
a Adjusted for age, country, education, body mass index, and alcohol consumption.
b Adjusted for variables in model A and all solvents.
c Adjusted for variables in model B and regression model performed respectively with stepwise backward and stepwise forward variable selection.
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exposure in model B indicating no strong association.
Occupational exposure to oxygenated solvents was 
not associated with MBC except for ethylene glycol in the 
least-adjusted model based on five ever-exposed cases. 
In order to estimate the stability of the results, we 
repeated the analyses using 10-year lagtime between 
exposure and diagnosis or interview (table 4). Overall, 
we observed a shift towards null results. OR for benzene 
were lower and not statistically significant anymore, 
while the association between exposure to TCE and MBC 
was more stable. OR≈2 (not significant) were found in 
association with ethylene glycol exposure. The stepwise 
analysis selected TCE (statistically significant) and eth-
ylene glycol, but not benzene.
Results were not substantially modified in sensitiv-
ity analyses performed by excluding the hospital-based 
cancer controls in all countries (supplemental table S1, 
www.sjweh.fi/show_abstract.php?abstract_id=3717).
Discussion 
In this European case–control study on MBC, one of 
the largest ever conducted, occupational exposure to 
organic solvents was assessed using a detailed JEM. 
High exposure to TCE was significantly associated with 
a doubling of the risk of MBC, a finding that remained 
Table 4. Odds ratios (OR) for male breast cancer according to occupational exposures to organic solvents with 10-year lag time period. 
[CES=cumulative exposure score; CI=confidence interval; KDF=kerosene/diesel oil/fuels oil; SBP=special-boiling-point spirits]






Model A a Model B b Model C c
OR 95% CI OR 95% CI OR 95% CI
Benzene
Not exposed 91 1762 1.0 reference 1.0 reference Not selected 
>0–<0.51 8 70 1.8 0.7–4.6 1.8 0.7–4.7   
≥0.51 5 69 1.7 0.6–5.0 1.6 0.5–4.9   
Gasoline
Not exposed 96 1805 1.0 reference 1.0 reference Not selected
>0–<0.09 4 49 1.0 0.4–2.7 1.0 0.4–2.8   
≥ 0.09 4 47 1.1 0.3–3.2 0.8 0.2–2.8   
SBP
Not exposed 98 1823 1.0 reference 1.0 reference Not selected
0–1.10 3 39 1.2 0.4–4.1 0.9 0.2–2.1   
≥1.10 3 39 1.2 0.3–4.2 0.7 0.1–2.4   
White spirits
Not exposed 80 1559 1.0 reference 1.0 reference Not selected 
0–0.05 11 172 1.2 0.6–2.3 1.1 0.6–2.2   
≥0.05 13 170 1.2 0.6–2.6 1.1 0.5–2.5   
KDF
Not exposed 86 1648 1.0 reference 1.0 reference Not selected 
0–0.05 8 126 1.6 0.8–3.0 1.4 0.7–2.8   
≥0.05 10 127 1.3 0.6–2.8 1.0 0.5–2.4   
Trichloroethylene
Not exposed 64 1363 1.0 reference 1.0 reference 1.0 reference
0–15.30 15 269 1.2 0.6–2.2 1.0 0.5–1.9 1.2 0.6–2.1
≥15.30 25 269 2.2 1.3–3.6 1.6 0.8–2.9 1.9 1.2–3.2
Methylene chloride
Not exposed 99 1826 1.0 reference 1.0 reference Not selected 
0–9.37 3 37 0.9 0.3–3.0 1.0 0.3–3.5   
≥9.37 2 38 1.0 0.4–2.5 1.1 0.4–3.2   
Alcohol
Not exposed 97 1763 1.0 reference 1.0 reference Not selected 
0–3.48 4 69 0.5 0.2–1.4 0.5 0.2–1.5   
≥3.48 3 69 0.7 0.3–1.9 0.7 0.2–1.9   
Ketones/esters
Not exposed 95 1790 1.0 reference 1.0 reference Not selected 
0–7.00 5 56 2.1 0.8–5.5 1.7 0.6–5.1   
≥7.00 4 55 1.9 0.7–5.4 1.4 0.4–4.8   
Ethylene glycol
Not exposed 101 1878 1.0 reference 1.0 reference 1.0 reference
Exposed 3 23 2.3 0.9–5.6 2.1 0.7–6.3 1.8 0.8–3.9
Tetra-hydrofuran
Not exposed 102 1895 1.0 reference 1.0 reference Not selected 
Exposed 2 6 0.5 0.1–2.4 0.6 0.1–3.0
a Adjusted for age, country, education, body mass index and alcohol consumption.
b Adjusted for variables in model A and all solvents. 
c Adjusted for variables in model A and stepwise selection of solvents.
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stable in different models and after accounting for a 
10-year lag time period. A dose–response trend was also 
indicated. In addition, a possible role for benzene and 
ethylene glycol in the etiology of MBC was suggested.
Petroleum solvents
The toxicity of benzene has been largely proven towards 
leukemia risk, and the IARC has classified benzene as a 
carcinogen (group 1) (12). It is generally recognized that 
aromatic hydrocarbons, such as benzene or methylene 
chloride, are mammary carcinogens in animals (7, 8, 
32, 33). Benzene induces oxidative stress, is genotoxic 
and immunosuppressive. It causes genomic instabil-
ity and induces apoptosis (12). In a study on female 
mice, benzene-induced mammary tumors exhibited a 
distinct pattern in the p53 and H-ras mutations com-
pared to spontaneous tumors, suggesting that benzene 
induces specific genetic alterations (34). In addition, 
benzene and other aromatic hydrocarbons have exhib-
ited endocrine-disrupting properties (35, 36) making the 
mammary gland more prone to tumor cell proliferation 
through hormonal mechanisms (37, 38).
In our study, exposure to benzene was associated 
with MBC, although the highest OR was found in the 
low-exposure group. Overall, this is consistent with the 
two-fold increased OR of MBC among motor vehicle 
mechanics and painters with known exposure to benzene 
previously reported in the same study population (25). 
According to the JEM, in addition to motor vehicle 
mechanics and painters, the most frequent occupations 
involving exposure to benzene included machinery fit-
ters, shoe makers, printers, precision-instrument makers, 
tire makers and vulcanizers. To explain the non-mono-
tonic dose–response curve between benzene exposure 
and MBC in our study, it is possible that the participa-
tion rate of the most highly exposed cases was reduced, 
eg, because of survival bias, thus leading to a smaller 
OR in the high exposure group. It is also possible that 
the risk of health outcome induced at low doses of ben-
zene exposure does not increase linearly at higher doses, 
as is frequently observed in studies on health effects of 
endocrine disrupting chemicals (39). Several epidemio-
logical studies have examined breast cancer in men or 
women in relation to benzene exposure. One study has 
evaluated the risk of MBC associated with exposure to 
benzene among US marines exposed to drinking water 
contaminated with solvents (40), but no association was 
found. However, the context and route of exposure were 
not the same as in our study and exposure levels were 
very low. As regards female breast cancer, population-
based or occupational cohort studies reported positive 
associations with occupational exposure to benzene 
(17, 18, 41), but other did not (19, 42). However, most 
studies did not assess benzene exposure levels quanti-
tatively. One study among shoe factory workers in Italy 
reported a two-fold increased standardized incidence 
ratio among women exposed to benzene >40 ppm years, 
but this results was based on only one case (41). In total, 
our study provides some support for the hypothesis that 
benzene may increase breast cancer risk, but this should 
be scrutinized in further studies. 
Apart from benzene, petroleum solvents in our 
analysis were complex mixtures of polycyclic aromatic 
hydrocarbons (PAH). We found elevated OR for white 
spirits, but the association disappeared when benzene 
was included in the model, suggesting that benzene 
content in white spirits explains this association. Previ-
ous studies on MBC reported no association between 
MBC mortality and PAH exposure (23) or a doubling of 
MBC incidence in workers exposed to PAH or gasoline 
(24). Occupational exposures to aromatic, aliphatic and 
alicyclic hydrocarbon solvents were positively associ-
ated with female breast cancer in some studies (16, 20). 
However, other studies gave inconsistent or null results 
(19, 42, 43). In another study, PAH DNA adducts, con-
sidered as a body-burden measure of exposure to PAH of 
any source, were more frequent in female breast cancer 
patients than controls (44). In total, these studies are 
very sparse, are based on weak exposure characteriza-
tion, and do not allow to conclude about breast cancer 
risk in relation to petroleum derivatives in general.
Exposure to chlorinated solvents
TCE is one of the most important chlorinated solvents, 
and the IARC recently upgraded it from group 2A (prob-
ably carcinogenic to humans) to group 1 (carcinogenic 
to humans) based on epidemiological and animal evi-
dence of a role in the risk of kidney cancer (13). TCE 
is metabolized to multiple mutagenic and carcinogenic 
metabolites that contribute to the carcinogenicity of 
the parent compound via genotoxic or non-genotoxic 
mechanisms (45). However, the biological mechanisms 
that could explain an excess breast cancer risk associated 
with TCE exposure are not known.  
We found that TCE exposure was associated with an 
increased risk of MBC. This association was stable in 
different models, robust in the analysis accounting for 
a 10-year lagtime and reinforced by a dose–response 
trend. The most frequent occupations exposed to TCE in 
our data were motor mechanics, machine fitters, plumb-
ers and painters. Conversely, no consistent association 
with methylene chloride was detected in our study after 
adjustment for exposure to other solvents based on eight 
exposed cases, whereas no cases were exposed to the 
three remaining chlorinated solvents (perchloroethylene, 
chloroform and carbon tetrachloride). 
In the study of US marines exposed to contaminated 
drinking water, exposure to TCE did not increase the 
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risk of MBC (40). However exposure to TCE in this 
study (median cumulative exposure 159 ppb months) 
was several orders of magnitude lower than in our data. 
Previous studies on female breast cancer, including a 
large population-based cohort in Finland (20) and a 
cohort of military women in the US (15) occupationally 
exposed to TCE, reported no evidence of an association 
with exposure to chlorinated solvents. No association of 
breast cancer with urinary biomarkers of exposure to TCE 
was found in a Scandinavian study, which included 260 
female and 2 male cases (46). However, in an electron-
ics workers cohort study in Taiwan, an increased risk of 
female breast cancer in association with a long duration 
of exposure to chlorinated solvents was reported (47). 
Overall, results of epidemiological studies do not allow 
for the drawing of firm conclusions, but our data add to 
the evidence that TCE may play a role in breast cancer. 
Oxygenated solvents
Oxygenated solvents include a large variety of chemi-
cals. Among alcoholic solvents, ethanol has well-known 
carcinogenic effects on many organs including the 
breast. These effects have been investigated intensively 
among alcohol drinkers in numerous studies. However 
exposure to alcoholic solvents from occupational origin 
through inhalation or cutaneous absorption may have 
different effects on health. Exposure to oxygenated 
solvents in general has been known to cause reprotoxic 
or neurologic effects, but their carcinogenic properties 
are not documented. It has been shown for example, that 
female workers exposed to ethylene glycol ethers had 
prolonged menstrual cycles and time-to-pregnancy com-
pared to those who were not exposed (48, 49). Experi-
mental studies have also demonstrated an increased pro-
duction of progesterone in ovarian luteal cells exposed 
to ethylene glycol ethers (50, 51). It can be hypothesized 
that modifications of hormone synthesis in exposed 
women has an impact on breast cancer risk. 
Our findings suggest a possible role of occupational 
exposure to ethylene glycol in MBC. OR were ≈2 in 
the model without adjustment for other solvents and 
in the analyses (five exposed cases) and in the models 
accounting for a 10-year lag time (three exposed cases). 
Conversely, we did not observe any association with 
occupational exposure to alcohol (seven exposed cases), 
tetrahydrofuran (two exposed cases), and ketones/esters 
(nine exposed cases) in our study. The small number 
of cases in our data and the lack of known mechanistic 
pathway does not allow us to draw conclusions.
To the best of our knowledge, no study has evaluated 
the risk of MBC specifically associated with exposure 
to oxygenated solvents to date. One case–control study 
in Australia evaluated occupational exposure to alcohol 
solvents in women and found no association with female 
breast cancer (43). Of note, cohort studies of workers 
exposed to ethylene oxide, an intermediate chemical 
used in the production of ethylene glycol that is also 
used as a sterilizing agent for medical equipment, found 
that breast cancer incidence was increased in exposed 
women (52, 53). However, the data on breast cancer in 
relation to oxygenated solvents are sparse and require 
further investigations in groups of workers with well-
characterized exposure. 
Study strengths and limitations
As reported earlier (27), the number of eligible cases 
identified during the study period was close to the 
expected number, based on incidence data from cancer 
registries in the participating areas. The case participa-
tion rate was 85%. The overall participation rate among 
controls was 67%, but there were large disparities across 
countries. Among countries that used population controls, 
the response rate was low in Northern Europe (Denmark, 
Germany, and Sweden). A differential participation of 
cases and controls, eg, according to social class, is thus 
possible, but its effects on our results were attenuated by 
adjustment on education level. Selection bias could occur 
in countries using hospital-based controls, mainly colon 
cancer patients. However, the results were not different 
when the analyses were conducted separately for subjects 
recruited with a population- and hospital-based design. 
Regarding the quality of exposure assessment, we 
used a detailed JEM elaborated for assessing occupa-
tional exposures in France as far back as the 1950s 
and based on the expertise of experienced industrial 
hygienists, extensive literature review and relevant 
exposure monitoring data at the work places. Using a 
JEM is considered to be a less accurate method than 
expert judgment based on the review of individual job 
histories (54). Moreover, the same JEM were used for all 
countries, while the jobs and the job tasks could differ 
to some extent between European countries. This could 
have led to errors in exposure estimates, however mis-
classification errors are expected to be non-differential.
Although this is the largest case–control study ever 
conducted to evaluate the association of MBC and 
occupational exposure to organic solvents, an impor-
tant limitation is the relatively small number of cancer 
cases for certain exposures evaluated due to the rarity 
of the disease. This may lead to low statistical power 
for detecting significant associations or concluding 
on the lack thereof, particularly for the less-frequent 
exposures. However, our study permitted the detection 
of some associations between occupational factors and 
breast cancer that could have been difficult to observe 
in studies on women. 
Concluding remarks
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In conclusion, this study suggests that men occupation-
ally exposed to TCE, and possibly benzene or ethylene 
glycol, are at increased risk of breast cancer, a finding 
that conceivably can be extrapolated to female breast 
cancer. Mechanisms that can explain these associa-
tions are still to be elucidated. Further epidemiological 
studies should be conducted in populations with well-
characterized exposure to organic solvents in order to 
confirm these findings. 
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